|
A more recent version of this article appeared on September 23, 2005
Papers In Press, published online ahead of print July 29, 2005
J. Biol. Chem, 10.1074/jbc.M505486200
Submitted on May 19, 2005
Revised on July 20, 2005
Accepted on July 29, 2005
Cyclic GMP-dependent protein kinase regulates CCAAT enhancer-binding protein functions through inhibition of glycogen synthase kinase-3
Xin Zhao, Shunhui Zhuang, Yongchang Chen, Gerry R. Boss, and Renate B. Pilz
Department of Medicine, University of California San Diego, La Jolla, CA 92093-0652
Corresponding Author: rpilz{at}ucsd.edu
The CCAAT enhancer-binding protein C/EBP plays an important role in the regulation of gene expression during cell proliferation, differentiation, and apoptosis. We previously showed that C/EBP participates in cGMP-regulated transcription of c-fos in osteoblasts (Chen et al., Mol. Cell. Biol. 23:4066-82, 2003). In the present work, we show that cGMP/cGMP-dependent protein kinase (PKG) induced de-phosphorylation and activation of C/EBP by inhibiting glycogen synthase kinase-3 (GSK-3 ). Phosphorylation of GSK-3 on Ser9 negatively regulates the enzymes activity, and we found that PKG phosphorylated this site both in vitro and in vivo; the in vivo phosphorylation occurred rapidly and preceded C/EBP de-phosphorylation. Previous studies with GSK-3 inhibitors suggest that GSK-3 is a C/EBP kinase in resting cells. We determined that GSK-3 phosphorylated C/EBP in vitro on Thr189, Ser185, Ser181, and Ser177; C/EBP was phosphorylated on these same sites in intact, unstimulated osteoblasts, and phosphorylation was decreased in cGMP-treated cells. Mutation of the GSK-3 phosphorylation sites in C/EBP prevented C/EBP phosphorylation in resting cells, enhanced C/EBP DNA binding and led to increased target gene transactivation, mimicking the stimulatory effects of cGMP on C/EBP . cGMP regulation of C/EBP was disrupted by a mutant GSK-3 (Ala9) resistant to cGMP/PKG phosphorylation and inhibition. We conclude that cGMP increases the DNA binding potential of C/EBP by preventing the negative effects of GSK-3 phosphorylation.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Das, L. Xi, and R. C. Kukreja
Protein Kinase G-dependent Cardioprotective Mechanism of Phosphodiesterase-5 Inhibition Involves Phosphorylation of ERK and GSK3{beta}
J. Biol. Chem.,
October 24, 2008;
283(43):
29572 - 29585.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Kuhl, S. M. Ross, and K. W. Gaido
CCAAT/Enhancer Binding Protein {beta}, But Not Steroidogenic Factor-1, Modulates the Phthalate-Induced Dysregulation of Rat Fetal Testicular Steroidogenesis
Endocrinology,
December 1, 2007;
148(12):
5851 - 5864.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. E. Broderick, T. Zhang, H. Rangaswami, Y. Zeng, X. Zhao, G. R. Boss, and R. B. Pilz
Guanosine 3',5'-Cyclic Monophosphate (cGMP)/cGMP-Dependent Protein Kinase Induce Interleukin-6 Transcription in Osteoblasts
Mol. Endocrinol.,
May 1, 2007;
21(5):
1148 - 1162.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|